{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:15:07Z","timestamp":1788516907758,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009377","name":"Education Department of Hunan Province","doi-asserted-by":"publisher","award":["Hunan Talent Office [2022] No. 3"],"award-info":[{"award-number":["Hunan Talent Office [2022] No. 3"]}],"id":[{"id":"10.13039\/100009377","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61814-x","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T02:34:56Z","timestamp":1784514896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of pilocarpine for the treatment of presbyopia: a systematic review and meta\u2011analysis of randomized controlled trials"],"prefix":"10.1038","volume":"16","author":[{"given":"Huimei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangzhi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jubo","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"1","key":"61814_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40123-021-00410-w","volume":"11","author":"MB McDonald","year":"2022","unstructured":"McDonald, M. B. et al. Classification of presbyopia by severity. Ophthalmol. Therapy. 11 (1), 1\u201311 (2022).","journal-title":"Ophthalmol. therapy"},{"key":"61814_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.preteyeres.2018.09.004","volume":"68","author":"JS Wolffsohn","year":"2019","unstructured":"Wolffsohn, J. S. & Davies, L. N. Presbyopia effectiveness of correction strategies. Prog. Retin. Eye Res. 68, 124\u2013143 (2019).","journal-title":"Prog. Retin. Eye Res."},{"issue":"10","key":"61814_CR3","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.ophtha.2018.04.013","volume":"125","author":"TR Fricke","year":"2018","unstructured":"Fricke, T. R. et al. Global prevalence of presbyopia and vision impairment from uncorrected presbyopia: Systematic review, meta-analysis, and modelling. Ophthalmology 125 (10), 1492\u20131499 (2018).","journal-title":"Ophthalmology"},{"issue":"8","key":"61814_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/OPX.0000000000001913","volume":"99","author":"J Stokes","year":"2022","unstructured":"Stokes, J., Shirneshan, E., Graham, C. A., Paulich, M. & Johnson, N. Exploring the experience of living with and managing presbyopia. Optometry Vis. Sci. Off. Publ. Am. Acad. Optometry. 99 (8), 635\u2013644 (2022).","journal-title":"Optometry Vis. science: official publication Am. Acad. Optometry"},{"issue":"7","key":"61814_CR5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/ceo.12954","volume":"45","author":"H Kandel","year":"2017","unstructured":"Kandel, H., Khadka, J., Goggin, M. & Pesudovs, K. Impact of refractive error on quality of life: a qualitative study. Clin. Exp. Ophthalmol. 45 (7), 677\u2013688 (2017).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"61814_CR6","doi-asserted-by":"crossref","unstructured":"Katz, J. A. et al. Presbyopia\u2014a review of current treatment options and emerging therapies. Clin. Ophthalmol. (Auckland NZ). 15, 2167\u20132178 (2021).","DOI":"10.2147\/OPTH.S259011"},{"key":"61814_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1874364101711010059","volume":"11","author":"K Moussa","year":"2017","unstructured":"Moussa, K., Jehangir, N., Mannis, T., Wong, W. L. & Moshirfar, M. Corneal refractive procedures for the treatment of presbyopia. Open. Ophthalmol. J. 11, 59\u201375 (2017).","journal-title":"open. Ophthalmol. J."},{"issue":"9","key":"61814_CR8","first-page":"2","volume":"60","author":"S Socea","year":"2019","unstructured":"Socea, S., Mimouni, M., Andreja, V. & Blumenthal, E. Z. Drops for presbyopia: Results of CSF-1, a multicenter randomized double-masked placebo-controlled crossover study. Invest. Ophthalmol. Vis. Sci. 60 (9), 2 (2019).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"12","key":"61814_CR9","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3928\/1081597X-20191010-04","volume":"35","author":"R Mont\u00e9s-Mic\u00f3","year":"2019","unstructured":"Mont\u00e9s-Mic\u00f3, R. & Charman, W. N. Pharmacological strategies for presbyopia correction. J. Refract. Surg. (Thorofare NJ: 1995). 35 (12), 803\u2013814 (2019).","journal-title":"J. refractive Surg. (Thorofare NJ: 1995)"},{"issue":"4","key":"61814_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/ICU.0000000000000770","volume":"32","author":"B Orman","year":"2021","unstructured":"Orman, B. & Benozzi, G. Pharmacological strategies for treating presbyopia. Curr. Opin. Ophthalmol. 32 (4), 319\u2013323 (2021).","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"8","key":"61814_CR11","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1097\/OPX.0000000000000881","volume":"93","author":"EM Rueff","year":"2016","unstructured":"Rueff, E. M., Varghese, R. J., Brack, T. M., Downard, D. E. & Bailey, M. D. A survey of presbyopic contact lens wearers in a university setting. Optometry Vis. Sci. Off. Publ. Am. Acad. Optometry. 93 (8), 848\u2013854 (2016).","journal-title":"Optometry Vis. science: official publication Am. Acad. Optometry"},{"key":"61814_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.exer.2018.09.005","volume":"183","author":"CE Smith","year":"2019","unstructured":"Smith, C. E., Allison, R. S., Wilkinson, F. & Wilcox, L. M. Monovision: Consequences for depth perception from large disparities. Exp. Eye Res. 183, 62\u201367 (2019).","journal-title":"Exp. Eye Res."},{"key":"61814_CR13","doi-asserted-by":"crossref","unstructured":"Ludwig, L. & Seifert, R. The decline in the clinical relevance of pilocarpine and physostigmine monitored in pharmacology textbooks from 1878 to 2023: nine take-home messages for future (pharmacology) textbook authors (Naunyn-Schmiedeberg\u2019s Archives of Pharmacology, 2024).","DOI":"10.1007\/s00210-024-03558-x"},{"issue":"5","key":"61814_CR14","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/eye.2011.82","volume":"25","author":"E Lavik","year":"2011","unstructured":"Lavik, E., Kuehn, M. H. & Kwon, Y. H. Novel drug delivery systems for glaucoma. Eye (Lond. Engl.). 25 (5), 578\u2013586 (2011).","journal-title":"Eye (London England)"},{"issue":"2","key":"61814_CR15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s40123-022-00482-2","volume":"11","author":"MA Jackson","year":"2022","unstructured":"Jackson, M. A. et al. Vitro and in-eye comparison of commercial pilocarpine ophthalmic solution and an optimized, reformulated pilocarpine for presbyopia treatment. Ophthalmol. Therapy. 11 (2), 869\u2013879 (2022).","journal-title":"Ophthalmol. therapy"},{"issue":"4","key":"61814_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1001\/jamaophthalmol.2022.0059","volume":"140","author":"FW Waring GOt, Price Jr","year":"2022","unstructured":"Waring GOt, Price, F. W. Jr. et al. Safety and efficacy of AGN-190584 in individuals with presbyopia: The GEMINI 1 phase 3 randomized clinical trial. JAMA Ophthalmol. 140 (4), 363\u2013371 (2022).","journal-title":"JAMA Ophthalmol."},{"key":"61814_CR17","doi-asserted-by":"crossref","unstructured":"Haghpanah, N. & Alany, R. Pharmacological treatment of presbyopia: A systematic review. Eur. J. Transl. Myol. 32(3). (2022).","DOI":"10.4081\/ejtm.2022.10781"},{"issue":"4","key":"61814_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/ICU.0000000000000864","volume":"33","author":"BB Meghpara","year":"2022","unstructured":"Meghpara, B. B., Lee, J. K., Rapuano, C. J., Mian, S. I. & Ho, A. C. Pilocarpine 1.25% and the changing landscape of presbyopia treatment. Curr. Opin. Ophthalmol. 33 (4), 269\u2013274 (2022).","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"6","key":"61814_CR19","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.survophthal.2025.05.008","volume":"70","author":"KY Chen","year":"2025","unstructured":"Chen, K. Y., Chan, H. C. & Chan, C. M. Effectiveness and safety of anti-vascular endothelial growth factor therapies for macular edema in retinal vein occlusion: A systematic review and network meta-analysis of randomized controlled trials. Surv. Ophthalmol. 70 (6), 1067\u20131089 (2025).","journal-title":"Surv. Ophthalmol."},{"key":"61814_CR20","doi-asserted-by":"crossref","unstructured":"Farid, M. et al. Combination low-dose pilocarpine\/diclofenac sodium and pilocarpine alone for presbyopia: Results of a randomized phase 2b clinical trial. Clin. Ophthal. (Auckland NZ). 18, 3425\u20133439 (2024).","DOI":"10.2147\/OPTH.S476658"},{"issue":"2","key":"61814_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.clinthera.2023.12.005","volume":"46","author":"E Holland","year":"2024","unstructured":"Holland, E. et al. Efficacy and safety of CSF-1 (0.4% pilocarpine hydrochloride) in presbyopia: Pooled results of the NEAR phase 3 randomized. Clin. Ther. 46 (2), 104\u2013113 (2024).","journal-title":"Clin. Ther."},{"key":"61814_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ajo.2023.05.008","volume":"253","author":"S Kannarr","year":"2023","unstructured":"Kannarr, S. et al. Safety and efficacy of twice-daily pilocarpine HCl in presbyopia: The virgo phase 3, randomized, double-masked, controlled study. Am. J. Ophthalmol. 253, 189\u2013200 (2023).","journal-title":"Am. J. Ophthalmol."},{"issue":"1","key":"61814_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/j.jcrs.0000000000001313","volume":"50","author":"CW Lievens","year":"2024","unstructured":"Lievens, C. W. et al. Pilocarpine HCl 1.25% for treatment of presbyopia after laser vision correction: Pooled analysis of two phase 3 randomized trials (GEMINI 1 and 2). J. Cataract Refract. Surg. 50 (1), 57\u201363 (2024).","journal-title":"J. Cataract Refract. Surg."},{"issue":"2","key":"61814_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/joco.joco_262_23","volume":"36","author":"M Singh","year":"2024","unstructured":"Singh, M. et al. A systematic review and meta-analysis on the efficacy and safety of topical pilocarpine 1.25% in presbyopia treatment. J. Curr. Ophthalmol. 36 (2), 111\u2013121 (2024).","journal-title":"J. Curr. Ophthalmol."},{"issue":"6","key":"61814_CR25","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s40123-024-00935-w","volume":"13","author":"BM Shafer","year":"2024","unstructured":"Shafer, B. M. et al. Understanding perspectives on presbyopia and use of pilocarpine HCl 1.25% twice daily from participants of the phase 3 VIRGO study. Ophthalmol. Therapy. 13 (6), 1723\u20131742 (2024).","journal-title":"Ophthalmol. therapy"},{"issue":"5","key":"61814_CR26","doi-asserted-by":"publisher","first-page":"532","DOI":"10.6026\/973206300200532","volume":"20","author":"S Petkar","year":"2024","unstructured":"Petkar, S. & Chaitra, M. C. Correction of presbyopia using 0.5% pilocarpine eye drops among Indians. Bioinformation 20 (5), 532\u2013536 (2024).","journal-title":"Bioinformation"},{"issue":"12","key":"61814_CR27","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.4103\/IJO.IJO_130_24","volume":"72","author":"A Tripathi","year":"2024","unstructured":"Tripathi, A., Sebastian, S. C., Yadav, H., Khan, I. J. & Kamath, V. The effect of 2% pilocarpine on depth of field in different time intervals among presbyopic subjects. Indian J. Ophthalmol. 72 (12), 1795\u20131797 (2024).","journal-title":"Indian J. Ophthalmol."},{"issue":"8","key":"61814_CR28","first-page":"e839","volume":"41","author":"KY Chen","year":"2025","unstructured":"Chen, K. Y., Chan, H. C. & Chan, C. M. How effective is keratorefractive lenticule extraction surgery (KLEx) in reducing dry eye outcomes compared to LASIK? A systematic review and meta-analysis. J. Refract. Surg. (Thorofare NJ: 1995). 41 (8), e839\u2013e54 (2025).","journal-title":"J. refractive Surg. (Thorofare NJ: 1995)"},{"issue":"1","key":"61814_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10792-024-03300-9","volume":"44","author":"KY Chen","year":"2024","unstructured":"Chen, K. Y., Chan, H. C., Wei, L. Y. & Chan, C. M. Efficacy of gabapentin and pregabalin for treatment of post refractive surgery pain: A systematic review and meta-analysis. Int. Ophthalmol. 44 (1), 409 (2024).","journal-title":"Int. Ophthalmol."},{"issue":"1","key":"61814_CR30","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00210-025-04454-8","volume":"399","author":"KY Chen","year":"2026","unstructured":"Chen, K. Y., Chan, H. C. & Chan, C. M. Which topical ophthalmic drugs work best for Keratoconjunctivitis Sicca? A systematic review and meta-analysis. Naunyn. Schmiedebergs Arch. Pharmacol. 399 (1), 769\u2013782 (2026).","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"issue":"1","key":"61814_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/ICB.0000000000001309","volume":"18","author":"EA Eton","year":"2024","unstructured":"Eton, E. A. et al. Retinal cases brief. Rep. 18(1), 98\u2013100. (2024).","journal-title":"Retinal cases brief. Rep."},{"key":"61814_CR32","doi-asserted-by":"crossref","unstructured":"Eaddy, I. C., Moushmoush, O., Sabbagh, O., Barazi, M. D. & Sabbagh, O. Horseshoe retinal tear minutes after use of a new pilocarpine formulation in a presbyopic, emmetropic man. J. Vitreoretinal Dis. 24741264241255589. (2024).","DOI":"10.1177\/24741264241255589"},{"key":"61814_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ajo.2022.05.011","volume":"242","author":"H Al-Khersan","year":"2022","unstructured":"Al-Khersan, H., Flynn, H. W. Jr. & Townsend, J. H. Retinal detachments associated with topical pilocarpine use for presbyopia. Am. J. Ophthalmol. 242, 52\u201355 (2022).","journal-title":"Am. J. Ophthalmol."},{"key":"61814_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2024.10.035","volume":"271","author":"AM Elhusseiny","year":"2024","unstructured":"Elhusseiny, A. M. et al. Using real-world data to assess the association of retinal detachment with topical pilocarpine use. Am. J. Ophthalmol. 271, 1\u20136 (2024).","journal-title":"Am. J. Ophthalmol."},{"key":"61814_CR35","doi-asserted-by":"crossref","unstructured":"Wu, F., Zhao, Y. & Zhang, H. Ocular autonomic nervous system: An update from anatomy to physiological functions. Vis. (Basel Switz.) 6(1). (2022).","DOI":"10.3390\/vision6010006"},{"issue":"4","key":"61814_CR36","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.aopr.2024.09.001","volume":"4","author":"A Grzybowski","year":"2024","unstructured":"Grzybowski, A., Kapitanovaite, L. & Zemaitiene, R. An updated systematic review of pharmacological treatments for presbyopia. Adv. Ophthalmol. Pract. Res. 4 (4), 220\u2013225 (2024).","journal-title":"Adv. Ophthalmol. Pract. Res."},{"issue":"3","key":"61814_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/APO.0000000000000297","volume":"9","author":"A Grzybowski","year":"2020","unstructured":"Grzybowski, A., Markeviciute, A. & Zemaitiene, R. A review of pharmacological presbyopia treatment. Asia-Pac. J. Ophthalmol. (Phila. Pa). 9 (3), 226\u2013233 (2020).","journal-title":"Asia-Pacific J. Ophthalmol. (Philadelphia Pa)"},{"issue":"6","key":"61814_CR38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/08164622.2023.2279189","volume":"107","author":"M Waring GOt, Brujic","year":"2024","unstructured":"Waring GOt, Brujic, M. et al. Impact of presbyopia treatment pilocarpine hydrochloride 1.25% on night-driving performance. Clin. Exp. Optometry. 107 (6), 665\u2013672 (2024).","journal-title":"Clin. experimental optometry"},{"issue":"7","key":"61814_CR39","first-page":"25","volume":"9","author":"G Benozzi","year":"2020","unstructured":"Benozzi, G., Perez, C., Leiro, J., Facal, S. & Orman, B. Presbyopia treatment with eye drops: An eight year retrospective study. Transl. Vis. Sci. Technol. 9 (7), 25 (2020).","journal-title":"Translational Vis. Sci. Technol."},{"issue":"4","key":"61814_CR40","doi-asserted-by":"publisher","first-page":"100065","DOI":"10.1016\/j.xops.2021.100065","volume":"1","author":"FW Price Jr","year":"2021","unstructured":"Price, F. W. Jr. et al. Combinations of pilocarpine and oxymetazoline for the pharmacological treatment of presbyopia: Two randomized phase 2 studies. Ophthalmol. Sci. 1 (4), 100065 (2021).","journal-title":"Ophthalmol. Sci."},{"issue":"5","key":"61814_CR41","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/bjd.16442","volume":"179","author":"M Cifuentes","year":"2018","unstructured":"Cifuentes, M., Del Barrio-D\u00edaz, P. & Vera-Kellet, C. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sj\u00f6gren syndrome: A double-blind randomized controlled trial. Br. J. Dermatol. 179 (5), 1056\u20131061 (2018).","journal-title":"Br. J. Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61814-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61814-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61814-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:40:45Z","timestamp":1788514845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61814-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61814"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61814-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27784"}}